Caseware UK (AP4) 2024.0.164 2024.0.164 2024-09-302024-09-30true2023-10-01false31trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09229446 2023-10-01 2024-09-30 09229446 2022-10-01 2023-09-30 09229446 2024-09-30 09229446 2023-09-30 09229446 c:Director1 2023-10-01 2024-09-30 09229446 d:MotorVehicles 2023-10-01 2024-09-30 09229446 d:MotorVehicles 2024-09-30 09229446 d:MotorVehicles 2023-09-30 09229446 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 09229446 d:FurnitureFittings 2023-10-01 2024-09-30 09229446 d:FurnitureFittings 2024-09-30 09229446 d:FurnitureFittings 2023-09-30 09229446 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 09229446 d:OfficeEquipment 2023-10-01 2024-09-30 09229446 d:OfficeEquipment 2024-09-30 09229446 d:OfficeEquipment 2023-09-30 09229446 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 09229446 d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 09229446 d:Goodwill 2024-09-30 09229446 d:Goodwill 2023-09-30 09229446 d:CurrentFinancialInstruments 2024-09-30 09229446 d:CurrentFinancialInstruments 2023-09-30 09229446 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 09229446 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 09229446 d:ShareCapital 2024-09-30 09229446 d:ShareCapital 2023-09-30 09229446 d:RetainedEarningsAccumulatedLosses 2024-09-30 09229446 d:RetainedEarningsAccumulatedLosses 2023-09-30 09229446 d:AcceleratedTaxDepreciationDeferredTax 2024-09-30 09229446 d:AcceleratedTaxDepreciationDeferredTax 2023-09-30 09229446 c:FRS102 2023-10-01 2024-09-30 09229446 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 09229446 c:FullAccounts 2023-10-01 2024-09-30 09229446 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 09229446 e:PoundSterling 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure

Registered number: 09229446










LONDON PLASTIC SURGERY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
LONDON PLASTIC SURGERY LIMITED
REGISTERED NUMBER: 09229446

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
30,285
37,082

  
30,285
37,082

Current assets
  

Debtors: amounts falling due within one year
 6 
14,235
13,758

Cash at bank and in hand
 7 
41,009
24,781

  
55,244
38,539

Creditors: amounts falling due within one year
 8 
(70,211)
(63,833)

Net current liabilities
  
 
 
(14,967)
 
 
(25,294)

Total assets less current liabilities
  
15,318
11,788

Provisions for liabilities
  

Deferred tax
 9 
(5,754)
(7,046)

  
 
 
(5,754)
 
 
(7,046)

Net assets
  
9,564
4,742


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
9,464
4,642

  
9,564
4,742


Page 1

 
LONDON PLASTIC SURGERY LIMITED
REGISTERED NUMBER: 09229446
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




D Fallahdar
Director

Date: 27 June 2025

The notes on pages 3 to 10 form part of these financial statements.

Page 2

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


General information

The company is a private company limited by shares, and is incorporated in England and Wales. The address of its registered office is 14th Floor, Cavendish Square, London W1G 0PW.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on a going concern basis. The directors are confident that activity levels will allow the company to meet its liabilities as they fall due.

 
2.3

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.4

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Goodwill
Goodwill represents the difference between amounts paid on the cost of a business combination and
the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the
date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated
amortisation and accumulated impairment losses. Goodwill is amortised on a straight line basis to the
Profit and loss account over its useful economic life.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over thier estimated useful lives, on a reducing balance basis and using the straight-line method.

Depreciation is provided on the following basis:

Motor vehicles
-
25% reducing balance
Fixtures and fittings
-
3 years straight line
Office equipment
-
3 years straight line



 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.8

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.
Page 4

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)


2.8
Financial instruments (continued)


Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due within the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 5

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

 
2.12

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

Page 6

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.13

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.



3.


Employees




The average monthly number of employees, including directors, during the year was 3 (2023 - 1).

Page 7

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4.


Intangible assets




Goodwill

£



Cost


At 1 October 2023
205,000



At 30 September 2024

205,000



Amortisation


At 1 October 2023
205,000



At 30 September 2024

205,000



Net book value



At 30 September 2024
-



At 30 September 2023
-



Page 8

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

5.


Tangible fixed assets





Motor vehicles
Fixtures and fittings
Office equipment
Total

£
£
£
£



Cost 


At 1 October 2023
61,543
1,200
33,242
95,985


Additions
-
-
2,627
2,627



At 30 September 2024

61,543
1,200
35,869
98,612



Depreciation


At 1 October 2023
25,002
1,200
32,701
58,903


Charge for the year on owned assets
9,135
-
289
9,424



At 30 September 2024

34,137
1,200
32,990
68,327



Net book value



At 30 September 2024
27,406
-
2,879
30,285



At 30 September 2023
36,541
-
541
37,082


6.


Debtors

2024
2023
£
£


Prepayments and accrued income
14,235
13,758



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
41,009
24,781


Page 9

 
LONDON PLASTIC SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
24,165
7,176

Corporation tax
37,094
52,257

Accruals and deferred income
8,952
4,400

70,211
63,833



9.


Deferred taxation




2024


£






At beginning of year
(7,046)


Charged to profit or loss
1,292



At end of year
(5,754)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(5,754)
(7,046)

 
Page 10